 | • レポートコード：TPM-B05117 • 出版社/出版日：Transparency Market Research / 2018年4月4日 • レポート形態：英文、PDF、154ページ • 納品方法：Eメール • 産業分類：Healthcare |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、放射線皮膚炎の世界市場について調べ、放射線皮膚炎の世界規模、市場動向、市場環境、製品タイプ別（局所製剤、経口薬、被覆剤）分析、販売チャネル別（院内薬局、小売薬局店、オンラインストア）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、バリューチェーン分析、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・放射線皮膚炎の世界市場動向 ・放射線皮膚炎の世界市場環境 ・放射線皮膚炎のバリューチェーン分析 ・放射線皮膚炎の世界市場規模 ・放射線皮膚炎の世界市場規模：製品タイプ別（局所製剤、経口薬、被覆剤） ・放射線皮膚炎の世界市場規模：販売チャネル別（院内薬局、小売薬局店、オンラインストア） ・放射線皮膚炎の世界市場：地域別市場規模・分析 ・放射線皮膚炎の北米市場規模・予測 ・放射線皮膚炎のアメリカ市場規模・予測 ・放射線皮膚炎の中南米市場規模・予測 ・放射線皮膚炎のヨーロッパ市場規模・予測 ・放射線皮膚炎のアジア市場規模・予測 ・放射線皮膚炎の日本市場規模・予測 ・放射線皮膚炎の中国市場規模・予測 ・放射線皮膚炎の中東市場規模・予測 ・放射線皮膚炎のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Radiodermatitis Market: Overview
Radiodermatitis, also known as radiation dermatitis, is a peculiar symptom caused as a result of radiation therapy pertaining to the treatment of cancerous as well as noncancerous conditions, and has significant negative impact on a patient’s physical functionalities and quality of life. It has been estimated that in developed countries such as the U.S., Canada, Australia, the U.K, France, and Germany, nearly half of the patients who receive treatment for cancer was also subjected to radiation therapy during the illness, and about all of them experience some degree of skin reaction. As the cases of cancer escalates across the world, the demand in the global radiodermatitis is expected to increment at a considerable CAGR of 3.93% during the forecast period of 2017 to 2024.
This report, developed by a group of professional market research analysts, aspires to serve as a credible business tool for the stakeholders of this market. The report studies the prospects of various segments of the market, based on product, distribution channel, and geography, as well as profiles a number of leading players to understand the competitive landscape. Qualitative and quantitative assessment of all factors that may influence the demand for radiodermatitis has been provided in the report.
Global Radiodermatitis Market: Trends & Opportunities
According to the International Agency for Research on Cancer (IARC), there were 14.1 million new cases of cancer across the world, and the figure is estimated to reach up to 21.7 million by the end of 2030. This substantial patient volume is the primary driver of the global radiodermatitis market. In addition to that, increasing focus on product innovation as well as advancements in the existing products are also expected to favor the market in the near future. Growing number of private and public healthcare organizations, who are constantly trying to promote the awareness regarding radiodermatitis treatment and management, and rising number of clinical studies to evaluate the efficiency of radiodermatitis treatment are some of the other factors favoring the global radiodermatitis market.
Based on product, the global radiodermatitis market has been segmented into topical, oral medication, and dressings. While topical segment is sub-segmented into hydrophilic creams, corticosteroids, and others such as antibiotics, oral medical is further divided into corticosteroids and others such as antibiotics and oral analgesics, whereas dressing segment is further categorized into hydrogel, no sting barrier film, hydrocolloid, honey impregnated gauze, silicone coated dressing, and others such as silver leaf dressing and GM-CSF gauze. On the basis of dressing channel, the market has been bifurcated into hospital pharmacy, online store, and retail pharmacy store.
Global Radiodermatitis Market: Regional Outlook
Though the demand for radiodermatitis is growing in all regions across the globe, Asia Pacific currently serves the maximum demand, owing to higher percentage untapped patient-base. A number of emerging economies in the Asian region are situated in tropical region with humid weather conditions, in which the effect of radiation dermatitis is quite high. Extensive collaborations among the key players in order to increase their product portfolio and involvement of well-established pharmaceutical companies in this region on commercialization of their products are also expected to help them increment their shares in this region.
Companies mentioned in the research report
Smith & Nephew plc, 3M Healthcare, Acelity, Convatec, Inc., and Molnlycke Health Care are some of the key companies operating in this market.
Key Segments of the Global Radiodermatitis Market
Global Radiodermatitis Market, by Product
Topical
Corticosteroids
Hydrophilic Creams
Others (topical antibiotics)
Oral Medication
Corticosteroids
Other (oral analgesics, antibiotics, etc.)
Dressings
Hydrogel
Hydrocolloid
No Sting Barrier Film
Honey Impregnated Gauze
Silicone Coated Dressing
Others (GM-CSF gauze, silver leaf dressing, etc.)
Global Radiodermatitis Market, by Distribution Channel
Hospital Pharmacy
Retail Pharmacy Store
Online Store
Global Radiodermatitis Market, by Geography
North America
U.S.
Canada
Asia Pacific
China
Japan
Rest of APAC
Europe
U.K.
Germany
Rest of Europe
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
South Africa
Rest of Middle East & Africa
This report gives you access to decisive data such as:
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for the coming years
Key highlights of this report
Overview of key market forces propelling and restraining market growth
Up-to-date analyses of market trends and technological improvements
Pin-point analyses of market competition dynamics to offer you a competitive edge
An analysis of strategies of major competitors
An array of graphics and SWOT analysis of major industry segments
Detailed analyses of industry trends
A well-defined technological growth map with an impact-analysis
Offers a clear understanding of the competitive landscape and key product segments
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2. Assumptions and Research Methodology
Chapter 3. Executive Summary: Global Radiodermatitis Market
Chapter 4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Value Chain Analysis
Chapter 5. Global Radiodermatitis Market Analysis and Forecast, by Product
5.1. Key Findings
5.2. Introduction
5.3. Market Size (US$ Mn) Forecast, by Product
5.3.1. Topical
5.3.1.1. Corticosteroids
5.3.1.2. Hydrophilic Creams
5.3.1.3. Others (topical antibiotics)
5.3.2. Oral Medication
5.3.2.1. Corticosteroids
5.3.2.2. Others (analgesics, antibiotics, etc.)
5.3.3. Dressings
5.3.3.1. Hydrogel
5.3.3.2. Hydrocolloid
5.3.3.3. No Sting Barrier Film
5.3.3.4. Honey Impregnated Gauze
5.3.3.5. Silicone Coated Dressing
5.3.3.6. Others (silver leaf dressings, GM-CSF gauze, etc.)
5.4. Market Attractiveness Analysis, by Product, 2015
5.5. Key Trends
Chapter 6. Global Radiodermatitis Market Analysis and Forecast, by Distribution Channel
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Distribution Channel
6.3.1. Hospital Pharmacy
6.3.2. Retail Pharmacy Store
6.3.3. Online Store
6.4. Market Attractiveness Analysis, by Distribution Channel, 2015
Chapter 7. Pipeline Analysis
7.1. List of discontinued trials
7.2. Clinical trial data for open studies
Chapter 8. Global Radiodermatitis Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4. Market Attractiveness Analysis, by Region, 2015
8.5. Key Trends
Chapter 9. North America Radiodermatitis Market Analysis and Forecast
9.1. Key Findings
9.2. Introduction
9.3. Market Size (US$ Mn) Forecast, by Product
9.3.1. Topical
9.3.2. Oral Medication
9.3.3. Dressings
9.4. Market Size (US$ Mn) Forecast, by Distribution Channel
9.4.1. Hospital Pharmacy
9.4.2. Retail Pharmacy Store
9.4.3. Online Store
9.5. Market Size (US$ Mn) Forecast, by Country
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis, by Product, 2015
9.7. Market Attractiveness Analysis, by Distribution Channel, 2015
9.8. Key Trends
Chapter 10. Europe Radiodermatitis Market Analysis and Forecast
10.1. Key Findings
10.2. Introduction
10.3. Market Size (US$ Mn) Forecast, by Product
10.3.1. Topical
10.3.2. Oral Medication
10.3.3. Dressings
10.4. Market Size (US$ Mn) Forecast, by Distribution Channel
10.4.1. Hospital Pharmacy
10.4.2. Retail Pharmacy Store
10.4.3. Online Store
10.5. Market Size (US$ Mn) Forecast, by Country
10.5.1. U.K.
10.5.2. Germany
10.5.3. Rest of Europe
10.6. Market Attractiveness Analysis, by Product, 2015
10.7. Market Attractiveness Analysis, by Distribution Channel, 2015
10.8. Key Trends
Chapter 11. Asia Pacific Radiodermatitis Market Analysis and Forecast
11.1. Key Findings
11.2. Introduction
11.3. Market Size (US$ Mn) Forecast, by Product
11.3.1. Topical
11.3.2. Oral Medication
11.3.3. Dressings
11.4. Market Size (US$ Mn) Forecast, by Distribution Channel
11.4.1. Hospital Pharmacy
11.4.2. Retail Pharmacy Store
11.4.3. Online Store
11.5. Market Size (US$ Mn) Forecast, by Country
11.5.1. China
11.5.2. Japan
11.5.3. Rest of Asia Pacific
11.6. Market Attractiveness Analysis, by Product, 2015
11.7. Market Attractiveness Analysis, by Distribution Channel, 2015
11.8. Key Trends
Chapter 12. Latin America Radiodermatitis Market Analysis and Forecast
12.1. Key Findings
12.2. Introduction
12.3. Market Size (US$ Mn) Forecast, by Product
12.3.1. Topical
12.3.2. Oral Medication
12.3.3. Dressings
12.4. Market Size (US$ Mn) Forecast, by Distribution Channel
12.4.1. Hospital Pharmacy
12.4.2. Retail Pharmacy Store
12.4.3. Online Store
12.5. Market Size (US$ Mn) Forecast, by Country
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis, by Product, 2015
12.7. Market Attractiveness Analysis, by Distribution Channel, 2015
12.8. Key Trends
Chapter 13. Middle East & Africa Radiodermatitis Market Analysis and Forecast
13.1. Key Findings
13.2. Introduction
13.3. Market Size (US$ Mn) Forecast, by Product
13.3.1. Topical
13.3.2. Oral Medication
13.3.3. Dressings
13.4. Market Size (US$ Mn) Forecast, by Distribution Channel
13.4.1. Hospital Pharmacy
13.4.2. Retail Pharmacy Store
13.4.3. Online Store
13.5. Market Size (US$ Mn) Forecast, by Country
13.5.1. UAE
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis, by Product, 2015
13.7. Market Attractiveness Analysis, by Distribution Channel, 2015
13.8. Key Trends
Chapter 14. Competition Landscape
14.1. Market Share Analysis
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. 3M
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Acelity LP, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. BMG Pharma S.r.l.
14.3.3.1. Company Overview (HQ, business segments, employee strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Recent Developments
14.3.3.5. Strategic Overview
14.3.4. ConvaTec, Inc.
14.3.4.1. Company Overview (HQ, business segments, employee strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Derma Sciences Inc.
14.3.5.1. Company Overview (HQ, business segments, employee strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Intermed Pharmaceuticals
14.3.6.1. Company Overview (HQ, business segments, employee strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Recent Developments
14.3.6.5. Strategic Overview
14.3.7. Molnlycke Health Care
14.3.7.1. Company Overview (HQ, business segments, employee strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Smith & Nephew plc
14.3.8.1. Company Overview (HQ, business segments, employee strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Stratpharma AG
14.3.9.1. Company Overview (HQ, business segments, employee strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.9.5. Value Chain
14.3.10. Others
Table 1: Global Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 2: Global Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 3: List of Discontinued Clinical Trials
Table 4: List of Open Clinical Trials
Table 5: Global Radiodermatitis Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 6: North America Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 7: North America Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 8: North America Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 9: Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 10: Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 11: Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 12: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 13: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 14: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 15: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 16: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 17: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 18: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 19: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 20: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024